Reuters logo
BRIEF-Serendex Pharmaceuticals keeps objectives and timeliness unchanged
August 1, 2014 / 9:12 AM / 3 years ago

BRIEF-Serendex Pharmaceuticals keeps objectives and timeliness unchanged

Aug 1 (Reuters) - Serendex Pharmaceuticals A/S : * Maintains objectives and timelines unchanged * Says still expects to present the first results of pre clinical program in

late September 2014 * Says expects to start sales of GM-CSF (Molgradex) in a name patient program

end of October 2014 * Source text for Eikon * Further company coverage

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below